When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
RLMD - Relmada Therapeutics Non-GAAP EPS of -$5.30 misses by $1.28
Relmada Therapeutics Inc.
2023-03-23 16:02:15 ET
Relmada Therapeutics press release ( NASDAQ: RLMD ): FY Non-GAAP EPS of -$5.30 misses by $1.28 .
As of December 31, 2022, the Company had cash, cash equivalents, and short-term investments of approximately $148.3 million, compared to cash, cash equivalents, and short-term investments of approximately $211.9 million at December 31, 2021.